Your browser doesn't support javascript.
loading
Patterns of Recurrence in Upper Tract Transitional Cell Carcinoma: Imaging Surveillance.
Mao, Yun; Kilcoyne, Aoife; Hedgire, Sandeep; Preston, Mark A; McGovern, Francis J; Dahl, Douglas M; Harisinghani, Mukesh.
Afiliação
  • Mao Y; 1 Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Kilcoyne A; 2 Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.
  • Hedgire S; 2 Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.
  • Preston MA; 3 Department of Surgery, Division of Urology, Brigham and Women's Hospital, Boston, MA.
  • McGovern FJ; 4 Department of Urology, Massachusetts General Hospital, Boston, MA.
  • Dahl DM; 4 Department of Urology, Massachusetts General Hospital, Boston, MA.
  • Harisinghani M; 2 Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114.
AJR Am J Roentgenol ; 207(4): 789-796, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27382922
ABSTRACT

OBJECTIVE:

The objective of our study was to evaluate recurrence patterns of upper tract transitional cell carcinomas (UT-TCCs) after radical nephroureterectomy (RNU). MATERIALS AND

METHODS:

Sixty-eight patients (mean age, 78 years; 34 men and 34 women) with UT-TCC after having undergone RNU from 2001 to 2008 were included in this study. Radiologic examinations and clinical notes were reviewed to record tumor location, tumor morphology, histologic T stages and grades, lymphovascular invasion (LVI) status, and surgical procedures. Five-year imaging and clinical follow-up (2001-2013) findings were noted at 3, 6, 12, 18, 24, 36, 48, 60, and more than 60 months after RNU for recurrence pattern and tumor-free survival. Kaplan-Meier survival curves and Cox regression models were used to assess tumor-free survival and to perform a multivariate analysis.

RESULTS:

Forty-one postoperative recurrences were noted in 20 patients. The mean time to relapse was 16 months, and time to relapse ranged from 1 to 66 months. Tumor site (multifocal lesions involving both renal collecting system and ureter), tumor morphology (mass), T stage (muscle invasion [T2-T4]), histologic grade (grade 3), and the presence of LVI were identified as risk factors for postoperative recurrence in UT-TCC. T stage was the only independent risk factor.

CONCLUSION:

Urinary tract, lymph node, liver, bone, and lung recurrences were common in patients with UT-TCC and were detected most frequently at 3-24 months. Tumor site, tumor morphology, T stage, grade, and LVI status were associated with recurrence after RNU. T stage was the only independent predictor of tumor-free survival. Close surveillance for extra-urinary tract recurrences in high-risk groups and a shorter-interval follow-up of the urinary tract in low-risk patients with adjuvant chemotherapy are recommended. Identifying recurrence patterns in UT-TCC can aid in planning an effective tailored imaging surveillance strategy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: AJR Am J Roentgenol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China